In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Avadel Pharmaceuticals plc (NASDAQ: AVDL) closed the day trading at $12.87 down -3.96% from the previous closing price of $13.40. In other words, the price has decreased by -$3.96 from its previous closing price. On the day, 0.98 million shares were traded. AVDL stock price reached its highest trading level at $13.54 during the session, while it also had its lowest trading level at $12.68.
Ratios:
For a better understanding of AVDL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 2.82. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 12, 2024, initiated with a Buy rating and assigned the stock a target price of $27.
On March 05, 2024, Oppenheimer reiterated its Outperform rating and also lowered its target price recommendation from $27 to $29.
Needham reiterated its Buy rating for the stock on March 05, 2024, while the target price for the stock was revised from $20 to $22.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 16 ’24 when MCHUGH THOMAS S bought 2,000 shares for $14.50 per share. The transaction valued at 29,000 led to the insider holds 80,500 shares of the business.
McCamish Mark Anthony sold 75,000 shares of AVDL for $1,089,750 on Dec 28 ’23. The Director now owns 67,025 shares after completing the transaction at $14.53 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVDL now has a Market Capitalization of 1239001216 and an Enterprise Value of 1205286656. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.02 while its Price-to-Book (P/B) ratio in mrq is 17.62. Its current Enterprise Value per Revenue stands at 12.667 whereas that against EBITDA is -12.396.
Stock Price History:
Over the past 52 weeks, AVDL has reached a high of $19.09, while it has fallen to a 52-week low of $9.50. The 50-Day Moving Average of the stock is -17.19%, while the 200-Day Moving Average is calculated to be -16.58%.
Shares Statistics:
Over the past 3-months, AVDL traded about 1.29M shares per day on average, while over the past 10 days, AVDL traded about 1072040 shares per day. A total of 96.27M shares are outstanding, with a floating share count of 90.35M. Insiders hold about 6.15% of the company’s shares, while institutions hold 71.45% stake in the company. Shares short for AVDL as of 1724976000 were 11914676 with a Short Ratio of 9.22, compared to 1722384000 on 11368919. Therefore, it implies a Short% of Shares Outstanding of 11914676 and a Short% of Float of 14.16.
